VEGFC and angiosarcoma: This data suggests that angiosarcoma progression may not only be driven by VEGF-A/VEGFR2 signaling (which dominates vascular endothelial signaling), but also by VEGF-C/VEGFR3 which is largely involved in lymphangiogenesis and maintenance of the lymphatic endothelium.